Ketamine and Motivational Enhancement Therapy for the Treatment of Tobacco Use Disorder

Summary

The purpose of the study is to examine whether an investigational medication called ketamine is able to improve treatment outcomes for tobacco use disorder when delivered in conjunction with brief motivational enhancement therapy. Participants will receive ketamine assisted motivational enhancement therapy weekly for three weeks and there will be 2 follow up visits. All visits will also consist of questionnaires and saliva samples will be taken. The overall participation will last approximately 8 weeks.

Timeline

Start

2023-05-02

Primary completion

2024-06-30

Completion

2024-06-30

Drugs

Indications